CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00006512
NCT00006512N/ACompleted
CompareCT.gov

Characterizing a 5P-Linked BHR Susceptibility Locus

University of Chicago·observational·Posted Nov 21, 2000·Updated Jan 21, 2016

In Brief

An observational study for Asthma and Lung Diseases. Completed.

Detailed Summary

To identify the predisposing genes responsible for asthma and bronchial hyperresponsiveness (BHR) at region 5p13.3 in an inbred Hutterite community.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Lung Diseases
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 21, 2000
Enrollment StartSep 1, 2000
Primary CompletionAug 1, 2005
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 25.6 years ago